SCHEMBL2179467

SCHEMBL2179467

CC(C=O)C1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12216595 1.00
SCHEMBL7136561 0.97 ADH1A (0.41)
SCHEMBL21114287 0.97 ADH1A (0.41)
SCHEMBL11258783 0.97 ADH1A (0.41)
SCHEMBL1302104 0.97 ADH1A (0.41)
SCHEMBL21114300 0.97 ADH1A (0.41)
SCHEMBL21114234 0.97 ADH1A (0.41)
SCHEMBL21114321 0.97 ADH1A (0.41)
SCHEMBL12216593 0.97 ADH1A (0.41)
SCHEMBL96256 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4918056-A ANTITUMOR AGENTS HEALTH RESEARCH, INC. (ROSWELL PARK DIVISION) (US) 1990-04-17 US claimed
US-4321366-A Process of preparing 2-azido-2-deoxyarabinofuranosyl halides RESEARCH CORPORATION (US) 1982-03-23 US claimed
US-4230698-A ANTITUMOR AGENTS, VIRICIDES, AND MICROBIOCIDES RESEARCH CORPORATION (US) 1980-10-28 US claimed
EP-1470173-B1 TWO-CONSTITUENT POLYURETHANE COMPOSITION HAVING HIGH EARLY STRENGTH SIKA TECH AG (CH) 2017-03-01 EP disclosed
CN-105143217-A Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions CAYMAN CHEMICAL CO INC 2015-12-09 CN disclosed
CN-104583201-A Difluorolactam compounds as EP4 receptor selective agonists for use in the treatment of EP4 mediated diseases and conditions CAYMAN CHEMICAL CO INC 2015-04-29 CN disclosed
CN-101952275-B Modulators for amyloid protein beta HOFFMANN LA ROCHE 2014-06-18 CN disclosed
CN-101743246-B 2-oxo-2- (2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl) -acetamide derivatives and related compounds as antifungal agents F2G LTD 2013-07-17 CN disclosed
CN-102762560-A Disubstituted heteroaryl-fused pyridines NOVARTIS AG 2012-10-31 CN disclosed
US-8039641-B2 Tetrahydrofuro[3,2-b] pyrrol-3-one intermediates AMURA THERAPEUTICS LIMITED (GB) 2011-10-18 US disclosed
US-20110166191-A1 3-(2-amino-ethyl)-5-(3-cyclohexyl-propylidene)-thiazolidine-2,4-dione and its derivatives as multiple signaling pathway inhibitors and for the treatment of cancer ZHANG SHIJUN 2011-07-07 US disclosed
US-4133959-A Aryloxyalkyl diketones STERLING DRUG INC. (US) 1979-01-09 US disclosed
US-4089865-A Certain thiazole compounds SYNTEX (U.S.A.) INC. (US) 1978-05-16 US disclosed
US-4046801-A 13-Cis prostaglandin derivatives SYNTEX (U.S.A.) INC. (US) 1977-09-06 US disclosed
US-4039669-A DERMATOLOGICAL CONDITIONS, ACNE, STEROIDS STERLING DRUG INC. (US) 1977-08-02 US disclosed
US-4001421-A THIAZOLE CARDIOVASCULAR AGENTS SYNTEX (U.S.A.) INC. (US) 1977-01-04 US disclosed
US-3992437-A Polyhydrophenanthrene derivatives STERLING DRUG INC. (US) 1976-11-16 US disclosed
US-3982010-A Thiazole cardiovascular agents SYNTEX (U.S.A.) INC. (US) 1976-09-21 US disclosed
US-3941781-A Preparation of 3-alkylthiomethyl cephalosporins ELI LILLY AND COMPANY (US) 1976-03-02 US disclosed
US-3932482-A CARDIOTONIC STERLING DRUG INC. (US) 1976-01-13 US disclosed